glp 1 agonists vs sglt2 inhibitors Common systemic effects of either or GLP-1R Effect of combination treatment with
Description
D.et al (2021)
doi: 10.2337/db22-719-P
Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
Forecasting Framework and Scenario Modelling Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools
& Witten, Z
